International Clinical Trial: Phase 1 Study of huCART19-IL18-CD428z Cells for the Treatment of Patients With HIV With CD19+ Cancers

Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07891468) titled 'Phase 1 Study of huCART19-IL18-CD428z Cells for the Treatment of Patients With HIV With CD19+ Cancers' on Oct. 16.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: University of Pennsylvania

Condition: Non-Hodgkin Lymphoma Chronic Lymphocytic Leukemia Acute Lymphoblastic Leukemia Richter's Transformation

Intervention: Biological: huCART19-IL18-CD428z cells

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: January 2027

Target Sample Size: 6

Countries of ...